Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome

[1]  S. Amselem,et al.  De Novo Gain‐Of‐Function Variations in LYN Associated With an Early‐Onset Systemic Autoinflammatory Disorder , 2022, Arthritis & rheumatology.

[2]  R. Goldbach-Mansky,et al.  Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies. , 2021, The Journal of allergy and clinical immunology.

[3]  T. Kalina,et al.  Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK. , 2021, The Journal of allergy and clinical immunology.

[4]  M. Hallek,et al.  Constitutive activation of Lyn kinase enhances BCR responsiveness, but not the development of CLL in Eµ-TCL1 mice. , 2020, Blood advances.

[5]  A. Zarrin,et al.  Kinase inhibition in autoimmunity and inflammation , 2020, Nature reviews. Drug discovery.

[6]  E. Harris,et al.  Prominent Receptors of Liver Sinusoidal Endothelial Cells in Liver Homeostasis and Disease , 2020, Frontiers in Physiology.

[7]  Young Hwan Park,et al.  Dasatinib Inhibits Lyn and Fyn Src-Family Kinases in Mast Cells to Suppress Type I Hypersensitivity in Mice , 2020, Biomolecules & therapeutics.

[8]  M. McConnell,et al.  Single-Cell Transcriptomics Reveals Zone-Specific Alterations of Liver Sinusoidal Endothelial Cells in Cirrhosis , 2020, bioRxiv.

[9]  D. Gerhold,et al.  Stem Cell-Derived Endothelial Cell Model that Responds to Tobacco Smoke Like Primary Endothelial Cells. , 2020, Chemical research in toxicology.

[10]  J. Stow,et al.  Signalling, sorting and scaffolding adaptors for Toll-like receptors , 2019, Journal of Cell Science.

[11]  José Rivera-Torres,et al.  Src Tyrosine Kinase Inhibitors: New Perspectives on Their Immune, Antiviral, and Senotherapeutic Potential , 2019, Front. Pharmacol..

[12]  B. Smedsrød,et al.  Liver sinusoidal endothelial cell ICAM-1 mediated tumor/endothelial crosstalk drives the development of liver metastasis by initiating inflammatory and angiogenic responses , 2019, Scientific Reports.

[13]  C. Ponting,et al.  Resolving the fibrotic niche of human liver cirrhosis at single cell level , 2019, Nature.

[14]  H. Fuchs,et al.  Gain-of-function mutations in a member of the Src family kinases cause autoinflammatory bone disease in mice and humans , 2019, Proceedings of the National Academy of Sciences.

[15]  J. D. del Campo,et al.  Role of inflammatory response in liver diseases: Therapeutic strategies , 2018, World journal of hepatology.

[16]  S. Friedman,et al.  Hepatic stellate cells as key target in liver fibrosis. , 2017, Advanced drug delivery reviews.

[17]  A. Zarbock,et al.  Skap2 is required for β2 integrin–mediated neutrophil recruitment and functions , 2017, The Journal of experimental medicine.

[18]  K. Preston,et al.  A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity. , 2017, JCI insight.

[19]  J. Gong,et al.  Lyn kinase enhanced hepatic fibrosis by modulating the activation of hepatic stellate cells. , 2017, American journal of translational research.

[20]  B. Malissen,et al.  The Transmembrane Adaptor Protein SCIMP Facilitates Sustained Dectin-1 Signaling in Dendritic Cells* , 2016, The Journal of Biological Chemistry.

[21]  Sylvia Richardson,et al.  A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies , 2016, Science Translational Medicine.

[22]  S. Vukicevic,et al.  VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling , 2016, Journal of Cell Science.

[23]  Yin Liu,et al.  Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. , 2015, Annual review of immunology.

[24]  M. Moran,et al.  Tyrosine Phosphorylation of the Lyn Src Homology 2 (SH2) Domain Modulates Its Binding Affinity and Specificity* , 2015, Molecular & Cellular Proteomics.

[25]  Jingyan Han,et al.  A critical role for Lyn kinase in strengthening endothelial integrity and barrier function. , 2013, Blood.

[26]  E. Ingley.  Functions of the Lyn tyrosine kinase in health and disease , 2012, Cell Communication and Signaling.

[27]  G. Newton,et al.  Emerging mechanisms of neutrophil recruitment across endothelium. , 2011, Trends in immunology.

[28]  A. Weiss,et al.  SCIMP, a Transmembrane Adaptor Protein Involved in Major Histocompatibility Complex Class II Signaling , 2011, Molecular and Cellular Biology.

[29]  Sanaz Memarzadeh,et al.  Differential transformation capacity of Src family kinases during the initiation of prostate cancer , 2011, Proceedings of the National Academy of Sciences.

[30]  C. Lowell.  Src-family and Syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk. , 2011, Cold Spring Harbor perspectives in biology.

[31]  D. Wheeler,et al.  The role of Src in solid tumors. , 2009, The oncologist.

[32]  Hong Zhang,et al.  Multiple roles of Lyn kinase in myeloid cell signaling and function , 2009, Immunological reviews.

[33]  N. K. Williams,et al.  Crystal Structures of the Lyn Protein Tyrosine Kinase Domain in Its Apo- and Inhibitor-bound State* , 2009, Journal of Biological Chemistry.

[34]  T. Wynn,et al.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.

[35]  J. Roth,et al.  Site of blood vessel damage and relevance of CD18 in a murine model of immune complex-mediated vasculitis. , 2007, The Journal of investigative dermatology.

[36]  Bryan Heit,et al.  Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade , 2006, The Journal of experimental medicine.

[37]  M. Ginsberg.  Faculty Opinions recommendation of VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. , 2006 .

[38]  J. Gutkind,et al.  VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin , 2006, Nature Cell Biology.

[39]  F. Luscinskas,et al.  ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. , 2005, Blood.

[40]  R. Roskoski,et al.  Src protein-tyrosine kinase structure and regulation. , 2004, Biochemical and biophysical research communications.

[41]  C. Quilici,et al.  Sustained Activation of Lyn Tyrosine Kinase In Vivo Leads to Autoimmunity , 2002, The Journal of experimental medicine.

[42]  Timothy J. Yeatman,et al.  Activating SRC mutation in a subset of advanced human colon cancers , 1999, Nature Genetics.

[43]  N. Haboubi,et al.  Endothelial cell transformation in primary biliary cirrhosis: A morphological and biochemical study , 1990, Hepatology.

[44]  T. Roberts,et al.  Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src , 1987, Cell.

[45]  H. Varmus,et al.  Detection and enumeration of transformation-defective strains of avian sarcoma virus with molecular hybridization. , 1977, Virology.